CTOs on the Move

The Schroer Group

www.walkingtogetherijf.org

 
The Schroer Group is the parent organization of five family-owned, outcome-based companies, including Altercare Integrated Health Services, Absolute Health Services, Avalon Foodservice, Leverage Purchasing Group and Valor Health Plan. We are committed to delivering quality care to our patients and residents through skilled nursing, assisted living, outpatient rehabilitation, pharmacy, food distribution, group purchasing and Institutional Special Needs Insurance. The Schroer Group has been recognized by NorthCoast 99 for 18 years as one of the best places to work in Northeast Ohio. TSG Resources provides IT technical services for the Schroer Group family of companies.
  • Number of Employees: 1K-5K
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

CenterCare Inc

CenterCare Inc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DePuy

Depuy is engaged in the development, manufacture and sale of orthopaedic joint implants (primarily hips, knees and shoulders), spinal implants, related surgical instruments, trauma products and sports medicine soft goods. (Source: 10-K)

Validic

Validic provides a simple connection to secure, standardized data from the newest, most popular and most specialized digital health technologies - from wellness applications and wearables to fitness equipment and clinical devices. Mobile health technologies are reshaping patient engagement and population management opportunities for healthcare companies. Validic is powering this ecosystem to allow for the accelerated deployment of healthcare companies` strategic initiatives. Validic`s clients include health systems and providers, health plans and payers, corporate wellness companies, pharmaceuticals, health IT vendors, as well as app and device manufacturers.

VTS Medical Systems

VTS Medical Systems is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.